Dr. Prathyush V is a Consultant Medical Oncologist and Precision Oncologist at Apollo Cancer Centres, Bengaluru, with over a decade of experience in the diagnosis and management of solid tumors and hematological malignancies. He is recognized for delivering personalized, evidence-based cancer care by integrating precision oncology, molecular diagnostics, comprehensive genomic profiling (NGS), immunotherapy, targeted therapies, and multidisciplinary decision-making into routine clinical practice.
His clinical expertise encompasses the management of breast, lung, gastrointestinal, gynecological, genitourinary, head & neck, hepatobiliary, and other solid tumors, as well as hematological malignancies including leukemia, lymphoma, and multiple myeloma. With a strong focus on biomarker-driven treatment strategies, he actively participates in molecular tumor boards and incorporates the latest scientific advances into individualized patient care.
Dr. Prathyush has a special interest in advanced cancer therapeutics, including immunotherapy, targeted therapy, precision oncology, and cellular therapies such as CAR T-cell therapy. He is involved in evaluating suitable patients for advanced therapies, collaborates with multidisciplinary teams to optimize treatment strategies, and remains committed to bringing emerging innovations in oncology into clinical practice.
Beyond clinical excellence, Dr. Prathyush believes that compassionate care, empathy, and open communication are essential to every patient's cancer journey. He is committed to ensuring that patients and their families feel informed, supported, and confident throughout every stage of treatment. Every patient deserves an individualized treatment plan tailored to the biology of their disease. His approach combines scientific innovation, precision medicine, multidisciplinary collaboration, and patient-centered care to improve survival while preserving quality of life.
Solid Tumors – Breast, Lung, Gastrointestinal, Gynecological, Genitourinary, Head & Neck, and Hepatobiliary Cancers
Hematological Malignancies – Leukemia, Lymphoma, Multiple Myeloma, and Related Disorders
Precision Oncology & Personalized Cancer Care
Immunotherapy and Targeted Therapy
Comprehensive Genomic Profiling (NGS) and Biomarker-Driven Treatment
CAR T-cell Therapy and Cellular Immunotherapy Evaluation
Molecular Tumor Boards
Cancer Prevention, Early Detection, Survivorship, Supportive and Palliative Oncology Care
Awards & Achievements
Author and co-author of publications in peer-reviewed national and international journals.
Presenter at national and international oncology conferences.
Second Prize – Oral Paper Presentation, IJMPO 2020.
Active participant in multidisciplinary tumor boards, precision oncology initiatives, and clinical research.
Research & Publications
01
Dr. Prathyush is actively involved in clinical research and evidence-based oncology, with a strong interest in real-world outcomes, precision oncology, targeted therapies, and immunotherapy. He encourages participation in appropriate clinical trials whenever suitable, enabling eligible patients to access promising therapies while contributing to the advancement of cancer care.
02
Dose Dense Neoadjuvant Chemotherapy in Triple Negative Non-Metastatic Breast Cancer: A Real-World Experience – Indian Journal of Cancer (2021)
03
Immunotherapy in Patients with Lung Cancer with Driver Mutations: A Single-Centre Experience – Journal of Clinical Oncology (ASCO Proceedings)
04
Lenvatinib plus Everolimus in Metastatic Renal Cell Carcinoma Progressing on Immunotherapy: A Real-World Single-Centre Experience – Journal of Clinical Oncology (ASCO Proceedings)
05
Immunotherapy with Nivolumab after Progression on Lenvatinib in Advanced Hepatocellular Carcinoma: A Real-World Indian Experience – Journal of Clinical Oncology (ASCO Proceedings)
Frequently Asked Questions (FAQs)
Q: What types of cancers do you treat?
<p>I treat breast, lung, gastrointestinal, gynecological, genitourinary, head & neck, hepatobiliary cancers, as well as blood cancers including leukemia, lymphoma, and multiple myeloma.</p>
Q: What is precision oncology?
Precision oncology uses molecular and genetic testing (including NGS) to identify biomarkers that help personalize treatment for each patient's cancer.
Q: When is genomic profiling (NGS) recommended?
NGS is recommended for selected cancers, especially advanced or metastatic cancers, when the results may influence targeted therapy or clinical trial options.
Q: What is immunotherapy?
Immunotherapy helps the body's immune system recognize and fight cancer. It is effective for specific cancers based on clinical and biomarker criteria.
Q: What are targeted therapies?
Targeted therapies act on specific genetic or molecular abnormalities in cancer cells, often improving outcomes while reducing damage to normal tissues.
Q: Is chemotherapy always necessary?
No. Treatment depends on the cancer type and stage. Some patients benefit more from surgery, radiation, targeted therapy, immunotherapy, hormone therapy, or combinations of these.
Q: What is CAR T-cell therapy?
CAR T-cell therapy is an advanced cellular therapy used for selected blood cancers. Suitability depends on the disease, prior treatments, and overall health.
Q: Do you offer second opinions?
Yes. Comprehensive second opinions include review of pathology, imaging, molecular reports, and previous treatments to help patients make informed decisions.
Q: Are clinical trials available?
Eligible patients may be considered for appropriate clinical trials when they offer potential benefit and align with current evidence and treatment goals.
Q: How should I prepare for my first consultation?
Bring previous medical records, pathology reports, imaging studies, blood test results, current medications, and a list of questions or concerns.
Best Hospital Near me Chennai